Predictive and prognostic molecular markers in outcome of esophageal cancer
- 1 December 2006
- journal article
- review article
- Published by Oxford University Press (OUP) in Diseases of the Esophagus
- Vol. 19 (6), 425-432
- https://doi.org/10.1111/j.1442-2050.2006.00622.x
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- High Cyclooxygenase-2 Expression Following Neoadjuvant Radiochemotherapy Is Associated with Minor Histopathologic Response and Poor Prognosis in Esophageal CancerClinical Cancer Research, 2005
- Neoadjuvant chemoradiotherapy for esophageal carcinoma: A meta-analysisSurgery, 2005
- Prognostic Significance of Stromelysin-3 and Tissue Inhibitor of Matrix Metalloproteinase-2 in Esophageal CancerOncology, 2004
- Responders benefit from neoadjuvant radiochemotherapy in esophageal squamous cell carcinoma: results of a prospective phase-II trialEuropean Journal of Surgical Oncology, 2004
- Vascular endothelial growth factor in esophageal cancerJournal of Surgical Oncology, 2004
- Prognostic significance of vascular endothelial growth factor and cyclooxygenase 2 expression in patients receiving preoperative chemoradiation for esophageal cancerThe Journal of Thoracic and Cardiovascular Surgery, 2004
- Reduced expression of transforming growth factor‐β receptors is an unfavorable prognostic factor in human esophageal squamous cell carcinomaInternational Journal of Cancer, 2003
- Clinical Significance and Prognostic Value of Apoptosis Related Proteins in Superficial Esophageal Squamous Cell CarcinomaAnnals of Surgical Oncology, 2001
- p53, p21(Waf1/Cip1) and cyclin D1 protein expression and prognosis in esophageal cancerDiseases of the Esophagus, 1999
- p53 Status and the Efficacy of Cancer Therapy in VivoScience, 1994